Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Aldeyra Therapeutics, Inc. (ALDX) had Free Cash Flow of $-9.72M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-5.45M |
|
-- |
|
-- |
|
$5.85M |
|
$-5.85M |
|
$0.40M |
|
$-5.45M |
|
$-5.45M |
|
$-5.45M |
|
$-5.45M |
|
$-5.45M |
|
$-5.45M |
|
$-5.85M |
|
$-5.78M |
|
60.32M |
|
60.32M |
|
$-0.09 |
|
$-0.09 |
|
| Balance Sheet Financials | |
$47.38M |
|
$0.02M |
|
$0.16M |
|
$47.54M |
|
$9.66M |
|
-- |
|
-- |
|
$9.66M |
|
$37.89M |
|
$37.89M |
|
$37.89M |
|
60.32M |
|
| Cash Flow Statement Financials | |
$-9.70M |
|
$-0.02M |
|
$-15.23M |
|
$70.04M |
|
$45.09M |
|
$-24.95M |
|
$0.66M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.91 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Free Cash Flow |
$-9.72M |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-14.39% |
|
-14.39% |
|
-11.46% |
|
-14.39% |
|
$0.63 |
|
$-0.16 |
|
$-0.16 |
|